Results 321 to 330 of about 73,485 (336)
Some of the next articles are maybe not open access.

Oral mucositis

Anti-Cancer Drugs, 2011
Oral mucositis remains one of the most common and troubling side effects of standard chemoradiation regimens used for the treatment of head and neck cancer. Virtually all patients who receive cumulative radiation doses of more than 30 Gy that includes oral mucosal fields will develop the condition.
openaire   +2 more sources

Oral mucositis

Dental Clinics of North America, 2005
Oral mucositis refers to erythematous, erosive, and ulcerative lesions of the oral mucosa seen in two patient populations: (1) head and neck cancer patients undergoing radiation therapy to fields involving the oral cavity, and (2) patients receiving high-dose chemotherapy for cancer.
Rajesh V, Lalla, Douglas E, Peterson
openaire   +2 more sources

Rash and mucositis

Journal of Paediatrics and Child Health, 2020
Rumeysa Yalçinkaya   +5 more
openaire   +5 more sources

Gastrointestinal mucositis

Seminars in Oncology Nursing, 2004
To review the management of radiotherapy- and chemotherapy-induced gastrointestinal mucositis.Articles and research studies.Gastrointestinal damage is becoming a common dose-limiting toxicity. However, there is only limited research into the mechanism and possible treatment of this toxicity.It is important to document the frequency and severity of ...
Keefe, D., Gibson, R., Hauer-Jensen, M.
openaire   +3 more sources

Oral Mucositis

Clinical Journal of Oncology Nursing, 2006
Ms. J is a 55-year-old woman who was diagnosed with stage IIIA colon cancer three months ago. Prior to her diagnosis, she experienced an unintentional 17-pound weight loss. She underwent an exploratory laparotomy with colon resection. Following recovery from her surgery, she began an adjuvant chemotherapy regimen of 5-fluorouracil, leucovorin, and ...
openaire   +2 more sources

Exploiting mucosal surfaces for the development of mucosal vaccines

Vaccine, 2011
Mucosal immunity covers a variety of mucosal surfaces susceptible to different pathogens. This review highlights the diversity of mucosal tissues and the unique microenvironments in which an immune response is generated. It argues that tissue-specific factors present throughout mucosal tissues and lymph nodes determine the differentiation into IgA ...
openaire   +3 more sources

Mucosal Biotransformation

Toxicologic Pathology, 1988
About 4 million compounds have been described by chemists, and some 60,000 are presently on the market. The search for new chemicals with better properties and less toxicity continues, and future life quality will depend on our ability to find the safest compounds in each field of application.
openaire   +2 more sources

Role of mucosal adjuvants in mucosal immunization

Current Opinion in Gastroenterology, 1998
Charles O. Elson, Alfred R. Oliver
openaire   +2 more sources

Mucositis

2018
Emma Bateman   +3 more
openaire   +1 more source

Mucosal Immunity

2015
M C, Béné, G, Faure, J, Duheille
openaire   +2 more sources

Home - About - Disclaimer - Privacy